Printer Friendly

Articles from The Fly (October 22, 2018)

1-189 out of 189 article(s)
Title Author Type Words
AbbVie reports 'positive' data from Phase 2b/3 study of upadacitinib. 213
Adobe achieves global gender pay parity. 135
Aetna price target raised to $207 from $202 at Credit Suisse. 118
Allena Pharmaceuticals presents ALLN-346 data at ACR/ARHP. 103
Alpine says ALPN-101 demonstrates preclinical activity in inflammatory arthritis. 237 price target raised to $2,400 from $2,100 at Credit Suisse. 110
Ameren Missouri to acquire 157-megawatt wind facility in northwest Missouri. 141
Analyst says sell Union Pacific, Genesee & Wyoming on slowing demand. 595
AngloGold says Kibali Gold Mine seen delivering record performance in Q3. 169
Arconic calls active and implied volatility reaches 52-week highs. 128
Aslan Pharmaceuticals presents new data for varlitinib with COX, FOL at ESMO. 178
Asur reports total Q3 Passenger Traffic up 6.3%. 156
Athenex: 11 patients achieved partial remission in Oraxol trial. 135
Attis Industries secures Medicare license for Tulsa toxicology lab. 132
Aveo announces updated interim results from Phase 2 of TiNivo study. 290
Bank OZK price target lowered to $27 from $38 at Barclays. 106
Barington calls on Bloomin' directors to improve board oversight of management. 289
BeiGene announces preliminary data from pamiparib study at ESMO. 434
Biohaven gets FDA authorization to proceed, doses first subject with BHV-3500. 131
Bloomin' Brands says has had seven discussions with Barington since March 2017. 134
BP assumed with an Overweight at Simmons. 103
Bright Scholar to acquire 85% interest in eight kindergartens for RMB70.55M. 103
Bristol-Myers says Opdivo, low-dose Yervoy shows durable clinical benefit. 209
Bristol-Myers' Opdivo combination shows longer survival in renal cell carcinoma. 152
Brown & Brown to acquire Hays Companies insurance operations. 166
Call spreads in Melco as shares move off of 52-week lows. 103
Celsion announces GEN-1 overview published in oncology journal. 180
Chembio Diagnostics acquires opTricon GmbH for $5.5M in cash. 210
Citi sees Merck showing 'extraordinary' treatment effect, downgrades Bristol. 106
Citi upgrades Jacobs Engineering after 'home run' deal to sell EC&R business. 122
Clearbridge MLP and Midstream Fund reaffirms name change, amended policy. 220
Clearbridge MLP and Midstream Total Return Fund reaffirms name change. 226
CollPlant, United Therapeutics announce licensing and commercialization deal. 287
Columbia Sportswear names former Gap CFO Simmons to board. 114
Corbus data shows 'favorable' safety profiles maintained with Lenabasum. 352
CoreLogic to acquire Symbility Solutions for CAD159.5M. 108
Corvus Pharmaceuticals announces new data on CPI-444 at ESMO. 158
Court grants restraining order to Lauder against Deciem founder, WSJ reports. 115
CytomX Therapeutics presents clinical data from Probody platform and CX-072. 233
Danone reaffirms 2018 guidance of double-digit recurring earnings growth. 144
DBV submits Biologics License Application to FDA for Viaskin Peanut. 149
Eastside Health Network, Premera collaborate with Microsoft on new health plan. 144
eBay could attract private equity at current valuation, says Citi. 151
eBay launches new program for consumers to instantly sell smartphones. 125
EDF Renewables, Ameren Missouri enter agreement for Missouri wind project. 129
Eli Lilly announces 'positive' results for two Phase 3 studies of Taltz. 177
EnLink Midstream to acquire EnLink Midstream Partners. 536
Epizyme says tazemetostat showed clinically meaningful activity in ES patients. 133
Exelixis reports Phase 1b results of cabozantinib combination in carcinoma. Financial report 196
Fedspeak is front-loaded this week. 127
Fiat Chrysler confirms sale of Magneti Marelli to Calsonic Kansei for EUR 6.2B. 294
First Data to refinance revolving credit facility and certain other indebtedness. 147
Flexion 'very attractively priced' after selloff, says Wells Fargo. 186
Flexion to present data from Phase 2 Zilretta study at ACR. 206
Fly Intel: After Hours Movers. 116
Fly Intel: Pre-market Movers. 265
Fly Intel: Wall Street's top stories for Monday. 504
Fly Intel: What to watch in Caterpillar earnings report. 295
Fly Intel: What to watch in McDonald's earnings report. 517
Fly Intel: What to watch in telecom sector earnings reports. 479
Ford expanding test of autonomous vehicles to Washington, D.C. 223
Ford option volume is 2X daily average ahead of earnings. 136
FTC approves Praxair, Linde merger with conditions. 287
Full House Resorts receives acquisition proposal for $132.5M. 121
FX Update: The dollar continued to find buoyancy. 283
FX Update: The Yen has softened while the Dollar has been mixed. 196
Genentech Tecentriq plus chemo as initial treatment helped people with NSCLC. 109
Genomic Health reports results from multiple studies of Oncotype cancer tests. 194
Gilead, Galapagos NV announce publication of trial results with filgotinib. 484
Global Water Resources receives extension on taxable gain. 161
Goldman Sachs working on digital wealth product under Marcus brand, CNBC says. 108
Google's YouTube investing $20M in education resources for 'EduTubers'. 200
Gray Television reports proposed $2.15B incremental term loan. 139
H.C. Wainwright 'very encouraged' by Kura data, reiterates $31 price target. 114
Halliburton CEO says 'pleased with our overall financial results' for Q3. Financial report 270
Halozyme reports results of data for PEGPH20 combination. Financial report 277
Hasbro CEO says managing 'through a very disruptive year'. 265
HC2 Holdings to explore strategic alternatives for Global Marine subsidiary. 233
HealthStream CFO Gerard Hayden, Jr. resigns, Scott Roberts named interim CFO. 134
HealthStream sees FY18 revenue growth of 6%-8%, consensus $229.26M. 165
Helix Energy reports Q3 adjusted EBITDA $58.6M vs. $30.5M last year. Financial report 116
Hi-Crush Partners completes buyout of general partner for $96.25M. 239
HomeStreet reports Q3 core EPS 45c, consensus 41c. Financial report 107
IAMGold announces positive results from a feasibility study for Senegal project. 116
Icahn agrees to sell American Railcar in deal valued at approx. $1.75B. 243
Inovio presents data on Phase 1b INO-5150 study at ESMO. Report 150
Intelsat, SES, Eutelsat in transition on planning to support 5G deployment. 145
Ionis Pharmaceuticals presents Phase 1b/2 data of danvatirsen. 194
Iqvia price target raised to $131 from $97 at Piper Jaffray. 109
Iqvia reports Q3 adjusted EPS $1.42, consensus $1.39. Financial report 103
Izea to execute holiday influencer marketing program for Fortune 10 customer. 101
J&J says tetravalent 'significantly enhanced' HIV immune responses. 129
John Schnatter urges Papa John's board to change poison pill. 425
JPMorgan downgrades Canadian Solar to Underweight after 24% rally. 103
Kemper sees Q3 pre-tax catastrophe losses of $20M-$25M. 130
Kimberly-Clark CEO says profitability impacted by commodity, currency headwinds. 108
Kimberly-Clark provides update to 2018 guidance. 142
Kimberly-Clark says CEO succession a 'carefully planned, natural transition'. 117
KLX Energy to acquire Motley Services for total consideration of $148M. 173
Kony acquires innovation subsidiary of Umpqua Holdings, terms not disclosed. 176
Lancaster Colony acquires Bantam Bagels for $34M. 157
Lancaster Colony subsidiary acquired assets of Batnam Bagels for $34M. 154
Lennox raises FY18 estimated business interruption impact from tornado. 317
Loop Capital lowers price target on Lionsgate to $33 on disappointing film slate. 107
Louisiana-Pacific upgraded to Market Perform at BMO Capital on valuation. 106
Loxo 'highly likely' to win FDA approval next month, says Piper Jaffray. 116
Mallinckrodt to report interim data on H.P. Acthar Gel Phase 4 study at ACR/ARHP. 171
Melinta Therapeutics CEO Dan Wechsler steps down, John Johnson named interim. 114
Merck data will dampen enthusiasm for Aduro Biotech, says William Blair. 137
Merck says Keytruda imrpoved OS vs. SoC in KEYNOTE-048 trial. 272
Mirati Therapeutics provides sitravatinib update after meeting with FDA. 218
Molina Healthcare agrees to sell Pathways Health and Community Support. 107
Morgan Stanley says publishers in 'win-win' situation as consoles move to cloud. 143
NanoViricides CEO comments on company pipeline. 220
NCR Corp. to acquire JetPay for $5.05 per share. 195
Nektar Therapeutics plunges as Roche data seen as concern. 437
Neon Therapeutics presents Phase 1b data on NEO-PV01 vaccine. 188
Nike well positioned to weather potential tariffs, says Oppenheimer. 154
Notable companies reporting before tomorrow's open. 108
Novartis COMBI-AD study of Tafinlar. 167
Novocure announces publication of results of PANOVA phase 2 pilot trial. Clinical report 380
NuCana presents data from Phase 1 NUC-3373 study at ESMO. 141
NY Attorney General announces $65M settlement with Wells Fargo. 125
NY pulls 2,990 body cameras from use after one bursts into flames, NYT says. 105
Oil Action: Front-month WTI crude prices are up 0.5%. 102
On The Fly: Top five analyst downgrades. 185
On The Fly: Top five analyst initiations. 135
On The Fly: Top five analyst upgrades. 251
Oncolytics: Pelareorep more than doubles OS at recommended Phase 2 dose. 218
OncoMed presents interim results for navicixizumab with paclitaxel at ESMO. 171
One Liberty Properties acquires industrial property in Colorado for $12.8M. 121
Oracle launches new data cloud solution for B2B marketers. 212
Orgenesis enters collaboration with Hemogenyx for Hu-PHEC development. 158
Origin Agritech enters Share Subscription Agreement with Longhan Investment. 125
PayPal price target raised to $119 from $112 at BMO Capital. 101
Pebblebrook Hotel clarifies cash election may be made after October 23. 350
Perry Ellis announces completion of its acquisition in $437M transaction. 181
Piper says buy shares of Aimmune 'aggressively' at current levels. 106
PNC to roll out digital business lending platform with OnDeck in 2019. 165
Polaris Industries considering taking more aggressive actions to offset tariffs. 125
Praxair expects Linde transaction to close on October 31. 155
Protagonist Therapeutics presents data from PROPEL study of PTG-100. 169
RBB Bancorp reports Q3 EPS 48c, consensus 60c. Financial report 138
RedHill Biopharma presents data showing MAP US study met primary endpoint. Clinical report 282
Regenxbio announces exclusive worldwide license with Ultragenyx. 111
ResMed says it won German patent infringement case against Fisher & Paykel. 163
Roche data should concern Nektar bulls, says H.C. Wainwright. 163
Roche reports Phase 3 study of Alecensa met primary endpoint. 151
SCANA says SC judge indicated no final decision has been reached. 142
Second day of interest in Caterpillar weekly puts ahead of earnings. 135
Senseonics announces Aetna's positive coverage decision for Eversense. 118
Sinovac Biotech granted interim injunctive relief in falsified documents. 211
St. Joe Company, InterMountain break ground on New Towneplace Suites Hotel. 131
Strategy Analytics: Amazon Echo has 23% share of smart speakers in use. 185
Super Micro denies malicious chip report, undertaking 'complicated' review. 448
Sutro Biopharma initiated with an Outperform at Wedbush. 117
Sykes Enterprises to acquire Symphony Ventures Limited for $69M. 193
Tactical call or not, Nomura upgrades Intel to Buy with $50 target. 140
Takeda Pharmaceutical's Trintellix adds labeling data on sexual dysfunction. 158
TD Ameritrade reports Q4 adjusted EPS 92c, consensus 88c. Financial report 126
Teen survey positive for console publisher group, says Piper Jaffray. 127
Teen survey shows Apple remains dominant brand, says Piper Jaffray. 160
Teen survey shows Facebook weakness, Instagram strength, says Piper Jaffray. 128
Teen survey shows surprising share gains for Crocs, says Piper Jaffray. 128
Tendril, Google collaborate for energy info for Indiana Michigan Power customers. 157
Tesaro price target raised to $68 from $57 at Cantor Fitzgerald. 102
Theravance Biopharma reports data from TD-1473 Phase 1b study. 227
Tilray issues additional $25M of convertible senior notes. 148
Total assumed with an Overweight at Simmons. 104
Treasury Action: supply is heavy this week with about $270 B. 211
Treasury Market Outlook: Treasury yields have inched up. 224
Treasury's $84 B 3- and 6-month bill auctions were pretty well received. 146
Twilio 23% pullback this month a buying opportunity, says Piper Jaffray. 123
Twilio 23% pullback this morning a buying opportunity, says Piper Jaffray. 123
U.S. 3-month Libor has risen 1 bp to 2.4874%. 177
U.S. corporate bond update: action is likely to pick up. 103
U.S. equities are back in the green. 184
U.S. equities have rotated lower. 168
U.S. midterms are just 2 weeks +1 day away. 172
U.S. steelmakers shift focus to making tariffs go away, WSJ reports. 130
United Rentals upgraded to Buy at Argus on healthy U.S. market activity. 113
Universal Insurance announces expected financial impact from weather events. 219
Viomi Technology initiated with a Buy at Needham. 102
Walmart price target lowered to $105 at MKM Partners after analyst meeting. 109
Weatherford announces sale of laboratory service business for $205M in cash. 149
Wells Fargo 'pleased' to reach pact with NY Attorney General. 148
Yandex addresses market rumors on capital structure. 221
Zai Lab announces approval of Zejula for patients with relapsed ovarian cancer. 237
Zions Bancorp reports Q3 EPS $1.04, consensus 96c. Financial report 116

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters